• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

13
3
3
3
3

COUNTRY

1
1
1
1
1

CATEGORIES

  • 12
  • 11
  • 11
  • 9
  • 8
  • 6
  • 5
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

0
0
15
52

PUBLISHED

0
0
16
52

PRODUCT TYPE

52

Search "N-Gene Research Laboratories, Inc.-Therapeutic Competitors Report" returned 52 results.

Companion Diagnostics Markets (Cancer, Cardiovascular and Blood, Metabolic, Infection, Neurological, Others) Companion Diagnostics Markets (Cancer, Cardiovascular and Blood, Metabolic, Infection, Neurological, Others) - Product Thumbnail Image

Companion Diagnostics Markets (Cancer, Cardiovascular and Blood, Metabolic, Infection, Neurological, Others)

The global companion diagnostic market is on the rise, and companion diagnostic development is becoming a primary area of focus for pharmaceutical developers. Many companion diagnostics are now successfully...

August 2014
FROM

The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives

The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular...

May 2013
FROM

World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing)

In this market research report, Kalorama Information defines the current opportunity and a realistic future potential for personalized medicine in clinical testing. In addition to analysis of tests...

March 2012
FROM
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition - Product Thumbnail Image

The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition

The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition In nine best-selling editions, Shara Rosen (MBA, RT), has created authoritative market estimates and forecasted growth models...

August 2014
FROM

World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)

Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the IVD market.  As analyst Shara Rosen, R.T., MBA. details, in recent...

January 2013
FROM

Duchenne Muscular Dystrophy - Pipeline Review, H2 2014

Duchenne Muscular Dystrophy - Pipeline Review, H2 2014 Summary This, ‘Duchenne Muscular Dystrophy - Pipeline Review, H2 2014’, provides an overview of the Duchenne Muscular Dystrophy’s therapeutic...

July 2014
FROM

The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition

In eight best-selling editions, Shara Rosen has detailed the market for in vitro diagnostic (IVD) testing, throughout the world,  in one complete volume. The report, The Worldwide Market for In Vitro...

July 2012
FROM

Obesity - Pipeline Review, H2 2014

Obesity - Pipeline Review, H2 2014 Summary This, ‘Obesity - Pipeline Review, H2 2014’, provides an overview of the Obesity’s therapeutic pipeline. This report provides comprehensive information on...

September 2014
FROM

Biomarker Technology Platforms for Cancer Diagnoses and Therapies 2014

Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis....

July 2014
FROM

Parkinson's Disease - Pipeline Review, H2 2014

Parkinson's Disease - Pipeline Review, H2 2014 Summary This, ‘Parkinson's Disease - Pipeline Review, H2 2014’, provides an overview of the Parkinson's Disease’s therapeutic pipeline. This report...

October 2014
FROM

Duchenne Muscular Dystrophy - Pipeline Review, H1 2014

Duchenne Muscular Dystrophy - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Duchenne Muscular Dystrophy - Pipeline Review, H1 2014’, provides an overview of the Duchenne Muscular Dystrophy’s...

February 2014
FROM

Molecular Diagnostics Reports Bundle

The Molecular Diagnostics Reports Bundle includes the following publications at a 15% discount off the individual reports being purchased separately: - Molecular Diagnostics in Cancer Testing - Molecular...

November 2013
FROM

Parkinson's Disease - Pipeline Review, H1 2014

Parkinson's Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Parkinson's Disease - Pipeline Review, H1 2014’, provides an overview of the Parkinson's Disease’s therapeutic pipeline. This...

February 2014
FROM

The Global Market for Biomarkers: Cancer Markers, Cardiac Markers, Blood Markers, Endocrine Markers, Infectious Disease and Neurological Disease Markers

The effectiveness of biomarkers has made them essential to medicine, with successful products on the market and many products in development The report focuses on both the clinical biomarkers and research...

October 2013
FROM

The Worldwide Market for Cancer Diagnostics, 4th Edition

Since Kalorama Information last updated our comprehensive market report on cancer testing, changes in the industry abound. Developments that were novel two years ago such as the commercialization of...

April 2010
FROM

Type 2 Diabetes - Pipeline Review, H1 2014

Type 2 Diabetes - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2014’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline. This...

February 2014
FROM

Insulin Resistance - Pipeline Review, H2 2014

Insulin Resistance - Pipeline Review, H2 2014 Summary This, ‘Insulin Resistance - Pipeline Review, H2 2014’, provides an overview of the Insulin Resistance’s therapeutic pipeline. This report provides...

August 2014
FROM

Insulin Resistance - Pipeline Review, H1 2014

Insulin Resistance - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Insulin Resistance - Pipeline Review, H1 2014’, provides an overview of the Insulin Resistance’s therapeutic pipeline. This...

June 2014
FROM

Hepatitis C - Pipeline Review, H1 2015

Hepatitis C - Pipeline Review, H1 2015 Summary This, ‘Hepatitis C - Pipeline Review, H1 2015’, provides an overview of the Hepatitis C’s therapeutic pipeline. This report provides comprehensive information...

January 2015
FROM

Market for Antiviral Therapeutics and Vaccines

This report from Kalorama Information examines the burgeoning antiviral market, and provides a comprehensive analysis of both therapeutics and vaccines: AIDS and HIV therapeutics; hepatitis therapeutics...

January 1996
Loading Indicator

Our Clients

Innocent Drinks Ltd. Groupe Danone Cisco Systems, Inc. The World Bank Group Swarovski AG Owens Corning Corporation Swiss Reinsurance Company Ltd.